ACS
0.06
361.5%
CDR
0.015
-25%
PET
0.025
257.1%
FHS
0.003
-25%
EPXDA
0.25
51.5%
TGH
0.022
-21.4%
QFE
0.08
35.6%
GLL
0.008
-20%
AT1
0.034
25.9%
OEL
0.004
-20%
ATH
0.01
25%
OVT
0.004
-20%
TYX
0.005
25%
RLG
0.004
-20%
IVX
0.098
24.1%
TMX
0.004
-20%
FMR
0.315
23.5%
CZN
0.15
-16.7%
MRZ
0.32
20.8%
TEM
0.005
-16.7%
APC
0.012
20%
ZEU
0.01
-16.7%
CPN
0.112
19.1%
KNG
0.105
-16%
MBK
0.02
17.6%
GES
0.006
-14.3%
RAU
0.27
17.4%
XPN
0.012
-14.3%
ODY
0.034
17.2%
RB6
0.099
-13.9%
PDI
0.732
17.1%
IMI
0.013
-13.3%
C1X
0.09
16.9%
ASP
0.007
-12.5%
HCT
0.09
16.9%
DUB
0.014
-12.5%
COV
0.73
16.8%
NES
0.007
-12.5%
MGU
0.007
16.7%
RXR
4.68
-12.5%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AVITA Medical (ASX:AVH) signed an exclusive 5 year distribution agreement with Stedical Scientific

AVITA Medical (ASX:AVH) signed an exclusive five year distribution agreement with Stedical Scientific, to commercialise PermeaDerm® Biosynthetic Wound Matrix in the U.S. The matrix is cleared by the U.S. FDA and used for a variety of injuries | https://announcements.asx.com.au/asxpdf/20240111/pdf/05zbp446ftpyw0.pdf #FDA #PermeaDerm #AVH